Publications

Wang, Z., and A. F. Olumi. 2011. Diabetes, Growth Hormone-Insulin-Like Growth Factor Pathways and Association to Benign Prostatic Hyperplasia.

Niu, Y., R. Ge, L. Hu, C. Diaz, Z. Wang, C. L. Wu, and A. F. Olumi. 2011. Reduced Levels of 5-α Reductase 2 in Adult Prostate Tissue and Implications for BPH Therapy.

Ganapathy, M., R. Ghosh, X. Jianping, X. Zhang, R. Bedolla, J. Schoolfield, I. T. Yeh, D. A. Troyer, A. F. Olumi, and A. P. Kumar. 2009. Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model.

Olumi, A. F., and W. C. Dewolf. 2009. The Hybrid of Basic Science and Clinical Training for the Urologic Oncologist: Necessity or Waste?.

Zhang, X., X. Huang, and A. F. Olumi. 2009. Repression of NF-KappaB and Activation of AP-1 Enhance Apoptosis in Prostate Cancer Cells.

Pedrosa, I., M. R. Sun, M. Spencer, E. M. Genega, A. F. Olumi, W. C. Dewolf, and N. M. Rofsky. 2008. MR Imaging of Renal Masses: Correlation With Findings at Surgery and Pathologic Analysis.

Zhang, X., W. Li, and A. F. Olumi. 2008. Overcoming Resistance to Trail-Induced Apoptosis in Prostate Cancer by Regulation of C-FLIP.

Zhang, X., L. Zhang, H. Yang, X. Huang, H. Otu, T. A. Libermann, W. C. DeWolf, R. Khosravi-Far, and A. F. Olumi. 2007. C-Fos As a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells.

Zhang, L., X. Zhang, G. W. Barrisford, and A. F. Olumi. 2007. Lexatumumab (TRAIL-Receptor 2 MAb) Induces Expression of DR5 and Promotes Apoptosis in Primary and Metastatic Renal Cell Carcinoma in a Mouse Orthotopic Model.

Zhang, X., W. Li, and A. F. Olumi. 2007. Low-Dose 12-O-Tetradecanoylphorbol-13-Acetate Enhances Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptosis in Prostate Cancer Cells.